Nike Inc (NKE) Stock Price Today
Aura AI Summary
Key Stats
- $53.39BMarket Cap
- 38,150,546Volume
- Consumer CyclicalSector
- $74.5752W High
- $35.5152W Low
- 155 DaysTypical Hold Time
- $55.40BEnterprise Value
- 4.56%Div Yield
- 50% Sell | 50% BuyTrading Activity
Track Nike Inc (NKE) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Nike Inc has traded between a low of $35.51 and a high of $74.57, highlighting its annual price range. Buy and sell Nike Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Most Recent News
Masonglory, INLIF, and Apimeds stocks surge on strategic deals and strong results
Masonglory Limited's shares soared over 300% following its share swap deal to acquire a 20% stake in an Austrian construction firm, expanding its business scope. INLIF Limited gained about 74% after reporting strong first-half fiscal 2026 results wit...

Fed's first rate hike since 2023 may boost private credit ETF payouts after a year of declines.
The Federal Reserve raised interest rates for the first time since 2023, increasing the upper bound to 4.00% from 3.75%. This shift affects private credit ETFs like VanEck BDC Income ETF (BIZD) and Putnam BDC Income ETF (PBDC), which saw shrinking pa...

FDA approves Olumiant for treating severe alopecia areata in children 12 and older, offering new hope for hair regrowth.
The FDA has approved Olumiant (baricitinib), a once-daily pill, for treating severe alopecia areata (AA) in pediatric patients aged 12 and older. This approval is based on positive results from the BRAVE-AA-PEDS Phase 3 study, showing significant sca...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.